Where Do I Go?
This body of work brings together portraits made across
Where Do I Go? is Matar's photographic love letter to the women of
Having left
Presented in collaboration with Robert Klein Gallery, the exhibition reflects Leica's continued commitment to supporting artists whose work engages cultural identity and lived experience. This presentation also celebrates Matar as a
Additional Programming
Opening Reception (Leica Gallery): Thursday,
Joint Reception with Robert Klein Gallery: Saturday,
Artist Talk with
Exhibition Hours:
Leica Gallery Boston is open Monday through Saturday,
Leica Store and Gallery Boston
Please find further information at:
Nike Communications Inc.
E-mail: [email protected]
Internet: www.leica-camera.com
Leica Store and Gallery Boston
(857) 305-3609
About the Artist
Her work has been exhibited internationally at institutions including the Museum of Fine Arts, Boston; LACMA; Carnegie Museum of Art; ICA/
About Leica Camera
Leica Camera AG is an international, premium manufacturer of cameras, lenses and sports optics. As part of its growth strategy, the company has expanded its portfolio to include mobile imaging (smartphones) and the manufacture of high-quality spectacle lenses and watches and is also represented in the home cinema segment with its own projectors.
Leica Camera AG, having its headquarters in
The Leica brand stands for excellence in quality, German craftsmanship and industrial design, combined with innovative technologies. An integral aspect of the brand culture is the promotion of the culture of photography, with around 30 Leica Galleries worldwide, the Leica Akademie and international awards such as the Leica Hall of Fame Award and the Leica Oskar Barnack Award (LOBA).
View original content to download multimedia:https://www.prnewswire.com/news-releases/where-do-i-go-302704179.html
SOURCE Leica Camera USA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fosun International Garners Five Awards from Corporate Governance Asia
- Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NS
- Elefin Launches Trading Platform Providing Access to Global CFD and Forex Markets
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share